Atlas Trials

Effect of Antifibrotic Therapy on Regression of Myocardial Fibrosis After Transcatheter Aortic Valve Implantation (TAVI) in Aortic Stenosis Patients With High Fibrotic Burden

Clinical trial NCT05230901 · UNKNOWN

Trial details

NCT number
NCT05230901
Sponsor
University Medical Center Goettingen
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Aortic Stenosis, Severe
Start date
2022-02-23
Primary completion
2025-06-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.